Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6426159 | 0.89 | — | — | |
| SCHEMBL10366909 | 0.89 | — | — | |
| SCHEMBL4947312 | 0.89 | — | — | |
| SCHEMBL9156588 | 0.89 | CA1 (0.42) | — | |
| SCHEMBL48308 | 0.89 | — | — | |
| Potassium Ion SCHEMBL9688 | 0.89 | — | — | |
| SCHEMBL4843117 | 0.89 | — | — | |
| SCHEMBL7008604 | 0.89 | — | — | |
| SCHEMBL22070012 | 0.89 | — | — | |
| Lithium Ion SCHEMBL3889583 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080268044-A1 | Novel Process and Formulations | GLAXO GROUP LIMITED | 2008-10-30 | — | — | US | claimed |
| EP-1954282-A2 | NOVEL PROCESS AND FORMULATIONS | GLAXO GROUP LIMITED (GB) | 2008-08-13 | — | — | EP | claimed |
| WO-2007059500-A2 | NOVEL PROCESS AND FORMULATIONS | GLAXO GROUP LIMITED (GB) | 2007-05-24 | — | — | WO | claimed |
| CN-111238893-B | Extraction method of humoral cells for detecting lung cancer | 湖北泰康医疗设备有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-111238893-A | Method for extracting humoral cells for detecting lung cancer | 湖北泰康医疗设备有限公司 | 2020-06-05 | — | — | CN | disclosed |
| US-20080268044-A1 | Novel Process and Formulations | GLAXO GROUP LIMITED | 2008-10-30 | — | — | US | disclosed |
| EP-1954282-A2 | NOVEL PROCESS AND FORMULATIONS | GLAXO GROUP LIMITED (GB) | 2008-08-13 | — | — | EP | disclosed |
| WO-2007059500-A2 | NOVEL PROCESS AND FORMULATIONS | GLAXO GROUP LIMITED (GB) | 2007-05-24 | — | — | WO | disclosed |
| US-20050143593-A1 | Process for producing 2-aralkylpropionic acid derivative | KANEKA CORPORATION (JP) | 2005-06-30 | — | — | US | disclosed |
| EP-1466895-A1 | PROCESS FOR PRODUCING 2-ARALKYLPROPIONIC ACID DERIVATIVE | KANEKA CORPORATION (JP) | 2004-10-13 | — | — | EP | disclosed |